Leonardo Teixeira

Leo is a master operator, scholar, and scientist with extensive experience in building and leading the product development and operational efforts for companies, including Roche, ITP and GeneWEAVE. In his previous roles, Leo created and led teams that established a standard way to develop innovative diagnostics that incorporated machine learning driven development processes in the critical care environment and was responsible for the growth, sustainability, strategic planning and P&L of companies. Leo co-founded GeneWEAVE, a diagnostics company that developed rapid tests to detect and guide therapy choice for serious infections, which was acquired by Roche in 2015.

Leo received his BS and MS from Universidade Federal de Vicosa and his PhD in microbiology from Cornell University. He lives in Los Altos Hills, CA.

Leo is a co-founder, board member and Chief Operating Officer of Endpoint Health. He leverages his dynamic interests and skill set to oversee Endpoint Health’s clinical studies, product development and logistics efforts and guide the company towards its next groundbreaking achievement.